WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled the Teleflex Center for Antimicrobial Protection (TCAP), a dedicated arm of its Vascular Access business unit. The new center, set in Research Triangle, North Carolina, aims to address the growing threat of infections from multidrug-resistant organisms — often referred to as “superbugs.”
These infections pose significant risks to patients, potentially leading to severe complications and prolonged hospital stays. TCAP will serve as a hub for education and collaboration with infection prevention professionals, striving to be a valuable resource for patients, physicians, and healthcare organizations.
“Teleflex strives to deliver vascular access products that are designed to benefit both clinicians and patients by helping to reduce vascular access-related complications,” stated Lisa Kudlacz, President and General Manager of Teleflex Vascular. She emphasized TCAP’s dedication to antimicrobial catheter technology and its role in mitigating central line-associated bloodstream infections (CLABSI).
Under the leadership of Chuck Gartner, Director of Marketing – Strategic Initiatives, TCAP aims to provide high-quality products and services. The center will focus on pioneering catheter protection technologies and developing innovative vascular access devices, reinforcing Teleflex’s commitment to enhancing patient care and safety.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.